The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.
April 15th 2024
These data represent the largest single-center, long-term study on booster vaccines at a public hospital’s dermatology department in Japan.
Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma
View More
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Advances In™: Aligning Pathology and Oncology Efforts in the Community to Improve NSCLC Care
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma
View More
Presidential Candidates on Health Care Issues: Ben Carson
Part of an ongoing series that takes a high-level look at the positions of the leading nominees for President when it comes to political issues potentially impacting physicians, this installment focuses on Ben Carson.
Mass Drug Administration Yields Sustained Reductions in Scabies Infections
Study results suggest that mass treatment with ivermectin followed by active case finding can result in a significant and sustained reduction of the presence of both scabies and bacterial skin infections.
Retail Prices of Dermatologic Medications Rising Steeply
A study has identified an across-the-board increase in the retail prices of dermatologic medications. The findings are consistent with other recent studies of pharmacologics in other specialties, but other trends in health care and circumstances unique to dermatologic conditions make the problem more significant.
What Makes Treating Psoriatic Arthritis So Expensive?
New research on the cost of treating psoriatic arthritis indicates that, on average, the annual bill for medical care and prescription medication totals just under $20,000 per patient, but that total costs vary greatly among individual patients.
Connection between Parasites and Chronic Spontaneous Urticaria
A review in Allergy suggests a strong connection between some cases of chronic spontaneous urticaria and parasite infections. This connection has been suggested for more than 65 years, but this exhaustive review collects significant evidence for the presence of PI in some cases.
Presidential Candidates on Health Care Issues: Donald Trump
Part of an ongoing series that takes a high-level look at the positions of the leading nominees for President when it comes to political issues potentially impacting physicians, this installment focuses on Donald Trump.
New research designed to measure the accuracy and validity of a trio of tools designed to assess quality of life in psoriatic arthritis patients indicates that none are comprehensive enough to be used alone and suggests that caregivers use 2 of the assessments in tandem.
Psoriasis Treatment May Trigger Significant Adverse Effects
Study results suggest that a treatment for psoriasis and multiple sclerosis may induce a dangerous adverse effect, particularly in women. The finding is potentially important, because while treatment with fumaric acid esters has been around for more than 40 years, it is now being used more widely in the United States, Germany, and other areas.